Learn More
Apexbio Technology LLC TAK-438 1260141-27-2 200mg

Supplier: Apexbio Technology LLC A2308200
TAK-438 is a small-molecule inhibitor targeting gastric H K -ATPase It is designed to reversibly block potassium-competitive activity of this enzyme thereby suppressing gastric acid secretion TAK-438 exerts its biological activity primarily through direct potassium-competitive inhibition of the gastric H K -ATPase enzyme In animal studies TAK-438 demonstrates concentration-dependent inhibition of histamine-stimulated acid secretion in rats and dogs with effects persisting beyond 24 hours after oral administration Based on these pharmacological properties TAK-438 holds research potential in studies involving gastric acid physiology and acid-related gastrointestinal disorders
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.